Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Lexington, MA NAICS: 325411
U.S. Department of Labor's OFLC discloses 36 Labor Condition Application filings naming Takeda Pharmaceuticals America Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 22 H-1B petitions naming Takeda Pharmaceuticals America Inc. through FY2024, and approved nearly every one of them: 100% approved (22 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Takeda Pharmaceuticals America Inc. is listed in 36 DOL LCA filings, more filings than 94% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $166,021. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Lexington, MA.
Takeda Pharmaceuticals America Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
36 7021st of 122824 higher than 115,803 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $72,000–$370,800 .
DOL LCA release change
On 36 LCAs with comparable offered vs prevailing wages, Takeda Pharmaceuticals America Inc. averages about 21.7% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (44.4% of LCA filings).
Completed-year LCA counts fell from 12 in FY2023 to 7 in FY2025 (≈58% of the earlier year). Cumulative volume still 36.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$166,021
Well above portal avg
Total Workers
36
Small worker count
Compensation range for H-1B positions at Takeda Pharmaceuticals America Inc.
Wage vs. DOL Minimum
+21.7%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
44.4% of LCA filings
Full-Time Positions
100%
Primary Worksite County
LEXINGTON, MA
25% of LCA filings
Most frequently listed job titles at Takeda Pharmaceuticals America Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Manager, Field Operations & Solutions | 2 | $175,473 |
| Senior Analyst, Data Insights & Analytics | 2 | $99,333 |
| Project Manager | 2 | $128,656 |
| PDT DD&T Delivery Lead | 2 | $180,000 |
| Managing Partner, Takeda Digital Ventures | 2 | $370,800 |
| Manager, MDM Data Quality | 2 | $149,299 |
| Head of Data, Digital, and Technology | 2 | $200,000 |
| Executive Medical Science Liaison | 2 | $208,220 |
| Advanced and Patient Analytics Lead | 2 | $200,000 |
| System Compliance and MDM Lead | 1 | $160,000 |
| Sr. Business Analyst | 1 | $135,000 |
| Senior Project Manager, Continuous Improvement | 1 | $150,286 |
| Senior Medical Science Liason | 1 | $171,532 |
| Senior Analyst, Contract Adherence and C&P Support | 1 | $100,000 |
| People Solutions Process Performance Analyst | 1 | $119,616 |
Cross-state DOL neighbors for Takeda Pharmaceuticals America Inc. - LCA filing-count and offered-wage axes, outside MA.
Nearest cross-state employer filers by LCA filing count (36 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($166,021 here).
Takeda Pharmaceuticals America Inc. is listed in 36 DOL Labor Condition Application filings covering 36 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Takeda Pharmaceuticals America Inc. ranks #6857 by total LCA filing count (36 filings). 115,803 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Takeda Pharmaceuticals America Inc. has a 100% DOL certification rate, with 36 out of 36 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Takeda Pharmaceuticals America Inc.'s LCAs is $166,021. Listed wages range from $72,000 to $370,800 and are not verified actual compensation.
The top job titles in Takeda Pharmaceuticals America Inc.'s LCA filing records include Senior Manager, Field Operations & Solutions, Senior Analyst, Data Insights & Analytics, Project Manager. The most common listed title is Senior Manager, Field Operations & Solutions with 2 LCA filings at an average listed offered wage of $175,473. This does not establish actual job openings, hiring, or approved petitions.
Takeda Pharmaceuticals America Inc. is headquartered in Lexington, MA. Their H-1B workers are distributed across 6 states, with the most positions in MA, PA, GA.
No, Takeda Pharmaceuticals America Inc. is not classified as H-1B dependent.
Takeda Pharmaceuticals America Inc. is listed in 12 LCA filings in FY2023 and 6 in FY2026. The average listed offered wage increased from $125,381 to $187,898. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 36 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals America Inc.); CERT-SOLID · WAGE-ELITE vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 36 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals America Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 36 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals America Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 36 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals America Inc.); CERT-LOCK · WAGE-ELITE vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Takeda Pharmaceuticals America Inc.'s MICRO-BOOK.
Open the MA state board after the ABS peers. Takeda Pharmaceuticals America Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Takeda Pharmaceuticals America Inc.'s WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Takeda Pharmaceuticals America Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.